K112961 is an FDA 510(k) clearance for the CLO-SURPLUS P.A.D.. Classified as Hemostatic Wound Dressing Without Thrombin Or Other Biologics (product code QSY).
Submitted by Scion Cardio-Vascular, Inc. (Melbourne, US). The FDA issued a Cleared decision on October 31, 2011 after a review of 27 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.